Purpose: To propose a node-by-node matching method between MRI and pathology with 3D node maps based on preoperative MRI for rectal cancer patients to improve the yet unsatisfactory diagnostic performance of nodal status in rectal cancer.
Methods: This methodological study prospectively enrolled consecutive participants with rectal cancer who underwent preoperative MRI and radical surgery from December 2021 to August 2023. All nodes with short-axis diameters of ≥ 3 mm within the mesorectum were regarded as target nodes and were localized in three directions based on the positional relationship on MRI and drawn on a node map with the primary tumor as the main reference, which was used as a template for node-by-node matching with pathological evaluation. Patient and nodal-level analyses were performed to investigate factors affecting the matching accuracy.
Results: 545 participants were included, of whom 253 received direct surgery and 292 received surgery after neoadjuvant therapy (NAT). In participants who underwent direct surgery, 1782 target nodes were identified on MRI, of which 1302 nodes (73%) achieved matching with pathology, with 1018 benign and 284 metastatic. In participants who underwent surgery after NAT, 1277 target nodes were identified and 918 nodes (72%) achieved matching, of which 689 were benign and 229 were metastatic. Advanced disease and proximity to primary tumor resulted in matching difficulties.
Conclusion: An easy-to-use and reliable method of node-by-node matching between MRI and pathology with 3D node map based on preoperative MRI was constructed for rectal cancer, which provided reliable node-based ground-truth labels for further radiological studies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00261-025-04826-x | DOI Listing |
Cureus
February 2025
Department of Digestive Disease, Xiamen Chang Gung Hospital, Hua Qiao University, Fujian, CHN.
Endometriosis may become malignant, and its diagnosis is challenging, especially in rare extra-ovarian sites like the rectum. Here, we describe the case of a 42-year-old woman who presented with intermittent left lower abdominal discomfort for six months. A colonoscopy revealed a 1.
View Article and Find Full Text PDFDis Colon Rectum
March 2025
Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Background: Total neoadjuvant therapy has been introduced to enhance oncological outcomes and minimize toxicity in locally advanced rectal cancer, with the superiority between the induction and consolidation of therapy remains unclear.
Objective: Evaluate oncological and postoperative outcomes by comparing induction chemotherapy and consolidation chemotherapy with conventional chemoradiotherapy in patients with locally advanced rectal cancer.
Data Sources: Systematic searches of PubMed, Embase, and Cochrane databases were performed for studies published from their inception until June 2023.
Dis Colon Rectum
March 2025
Division of Colon and Rectal Surgery, University of Massachusetts, Memorial Medical Center, Worcester, Massachusetts.
Cancer Med
March 2025
Department of Experimental and Animal Pathology, Clinical Institute of Pathology, Medical University Vienna, Vienna, Austria.
Background: Enhanced protein expression of ALL1-fused gene from chromosome 1q (AF1Q) after (chemo)radiotherapy has been described in vitro, but is largely understudied in gastrointestinal cancer. We aimed to investigate AF1q expression in rectal cancer (RC) patients treated with short-term radiation therapy and a possible correlation with markers crucial for RC prognosis.
Methods: A cohort of 75 RC patients scheduled for surgery was defined and patients with moderately locally advanced tumors (cT3Nx) received preoperative hyperfractionated short-term radiation therapy (cumulative dose 25 Gy).
World J Gastroenterol
February 2025
Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong Province, China.
Background: The peritumoral region possesses attributes that promote cancer growth and progression. However, the potential prognostic biomarkers in this region remain relatively underexplored in radiomics.
Aim: To investigate the prognostic value and importance of peritumoral radiomics in locally advanced rectal cancer (LARC).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!